Experimental group:transnasal injection of hNSC

2 trials

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai tongji hospital

Conditions

Ischemic strokeParkinson’s disease

Early Phase 1

Evaluation of safety and efficacy of human neural stem cells in the treatment of early onset Parkinson's disease with motor complications

Active, not recruitingChiCTR1900024661

Shanghai tongji hospitalParkinson’s disease

Start: 2019-08-01Updated: 2021-12-13

Phase 1

A single center randomized controlled trial for human-derived neural stem cell in the treatment of ischemic stroke

RecruitingChiCTR1900022741

Renji Hospital, Shanghai Jiao Tong University School of MedicineIschemic stroke

Start: 2019-06-01Updated: 2022-03-07

Related Papers

Efficacy and safety of human-derived neural stem cell in patients with ischaemic stroke: study protocol for a randomised controlled trial

BMJ Open2022-11-018 citations